BioCentury
ARTICLE | Company News

Endo Pharmaceuticals Holding Inc., Qualitest Pharmaceuticals deal

October 4, 2010 7:00 AM UTC

Endo will acquire generics company Qualitest for about $1.2 billion in cash. Endo said the deal will increase its current generics business and enhance its portfolio of pain products. Endo expects the...